Authors

• David G. Standaert (ORCID: https://orcid.org/0000-0003-2921-8348)
• Victor S.C. Fung (ORCID: https://orcid.org/0000-0003-3085-2282)
• Michael J. Soileau (ORCID: https://orcid.org/0000-0002-3944-1327)
• Jason Aldred (ORCID: https://orcid.org/0000-0001-7441-0967)
• Diego Santos‐García (ORCID: https://orcid.org/0000-0002-3126-5111)
• Rajesh Pahwa (ORCID: https://orcid.org/0000-0003-3176-6466)
• Amy Spiegel (ORCID: https://orcid.org/0000-0001-9179-7964)
• К. Ray Chaudhuri (ORCID: https://orcid.org/0000-0003-2815-0505)
• Connie H. Yan (ORCID: https://orcid.org/0000-0003-1467-4666)
• Camille Carroll (ORCID: https://orcid.org/0000-0001-7472-953X)
• Irene A. Malaty (ORCID: https://orcid.org/0000-0001-6914-9223)
• Maurizio Facheris (ORCID: https://orcid.org/0009-0002-4854-6873)
• Tove Henriksen (ORCID: https://orcid.org/0000-0002-5171-1166)
• Thomas Kimber (ORCID: https://orcid.org/0000-0002-6496-7400)
• Jorge Zamudio (ORCID: https://orcid.org/0000-0002-7138-3032)
• Linda Harmer
• Ashwini Parab (ORCID: https://orcid.org/0000-0002-8136-1179)

Institutions

• Royal Adelaide Hospital (AU)
• King's College London (GB)
• University of Florida Health (US)
• Bispebjerg Hospital (DK)
• Inland Northwest Health Services (US)
• Westmead Hospital (AU)
• AbbVie (United States) (US)
• University of Alabama at Birmingham (US)
• University of Florida (US)
• University of Kansas Medical Center (US)
• Complexo Hospitalario Universitario A Coruña (ES)
• Dermatology Specialists (US)
• The University of Adelaide (AU)
• Newcastle University (GB)

Publication Details

Journal

Neurology and Therapy

Published

2025-10-04

DOI

https://doi.org/10.1007/s40120-025-00827-6

Primary Topic

Parkinson's Disease Mechanisms and Treatments

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Teva Pharmaceutical Industries
• Sunovion
• Wellcome Trust
• Parkinson's Foundation
• National Institute for Health and Care Research
• Parkinson's UK
• Ministerio de Economía y Competitividad
• H. Lundbeck A/S
• Instituto de Salud Carlos III